Neurochem to present at JPMorgan Healthcare Conference

About this update from Bluenergies Ltd.

[{"type":"text","content":"\n\n\n\nLAVAL, QC, Jan. 3 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM)\nannounces today that on Thursday, January 10, 2008, Dr. Francesco Bellini,\nChairman, President and CEO, will present Neurochem's overall strategy at the\n26th Annual JPMorgan Healthcare Conference to be held at the Westin\nSt. Francis Hotel, in San Francisco (CA). The presentation will take place at\n2:00 P.M. PST, in the Elizabethan A & B room.\n\n\nAbout Neurochem\n\n\nNeurochem Inc. is a global health company focused on the research,\ndevelopment and commercialization of products to provide innovative health\nsolutions to patients suffering from serious diseases.\n\n\nTo Contact Neurochem\n\n\nFor additional information on Neurochem and its drug development\nprograms, please call the North American toll-free number 1-877-680-4500 or\nvisit our Web Site at www.neurochem.com.\n\n\nCertain statements contained in this news release, other than statements\nof fact that are independently verifiable at the date hereof, may constitute\nforward-looking statements. Such statements, based as they are on the current\nexpectations of management, inherently involve numerous risks and\nuncertainties, known and unknown, many of which are beyond Neurochem Inc.'s\ncontrol. Such risks include but are not limited to: the impact of general\neconomic conditions, general conditions in the pharmaceutical and/or\nnutraceutical industry, changes in the regulatory environment in the\njurisdictions in which the Neurochem group does business, stock market\nvolatility, fluctuations in costs, and changes to the competitive environment\ndue to consolidation, that actual results may vary once the final and\nquality-controlled verification of data and analyses has been completed, as\nwell as other risks disclosed in public filings of Neurochem Inc.\nConsequently, actual future results may differ materially from the anticipated\nresults expressed in the forward-looking statements. The reader should not\nplace undue reliance, if any, on any forward-looking statements included in\nthis news release. These statements speak only as of the date made and\nNeurochem Inc. is under no obligation and disavows any intention to update or\nrevise such statements as a result of any event, circumstances or otherwise.\nPlease see the Annual Information Form of Neurochem Inc. for further ris...

More updates from Bluenergies Ltd.